Aspire Private Capital, LLC Exact Sciences Corp Transaction History

Aspire Private Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$90.37 - $122.49 $8,404 - $11,391	-93 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$89.51 - $118.04 $1,611 - $2,124	18 Added 24.0%	93 $11,000
Q1 2019 May 13, 2019	SELL	$61.98 - $96.5 $309 - $482	-5 Reduced 6.25%	75 $6,000
Q4 2018 Feb 25, 2019	BUY	$56.04 - $82.66 $4,034 - $5,951	72 Added 900.0%	80 $5,000
Q4 2018 Feb 14, 2019	BUY	$56.04 - $82.66 $448 - $661	8 New	8 $5,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.94B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Aspire Private Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Aspire Private Capital, LLC with notifications on news.